Literature DB >> 16131350

Intracellular colocalization and interaction of IGF-binding protein-2 with the cyclin-dependent kinase inhibitor p21CIP1/WAF1 during growth inhibition.

Xavier Terrien1, Elise Bonvin, Sophie Corroyer, Olivier Tabary, Annick Clement, Alexandra Henrion Caude.   

Abstract

It is presently unknown whether any member of the IGFBP (insulin-like growth factor binding protein) family directly participates in the control of cell proliferation. We have previously documented that induction of IGFBP-2 was associated with inhibition of DNA synthesis in lung alveolar epithelial cells. In the present study, we investigated the relationship between IGFBP-2 and the cell cycle inhibitor p21CIP1/WAF1 further. We used serum deprivation to inhibit the proliferation of MLE (mouse lung epithelial)-12 cells, and characterized the spatial localization of IGFBP-2. We found that growth inhibition, which was supported by the strong induction of p21CIP1/WAF1, was correlated with increased secretion of IGFBP-2 and, unexpectedly, with its increased localization in the nucleus and particularly in the cytoplasm. By coimmunoprecipitation, we discovered that IGFBP-2 is capable of binding to p21CIP1/WAF1. Interaction between these two proteins was further supported by colocalization of the proteins within growth-arrested cells, as visualized by confocal microscopy. Furthermore, this interaction increased with the duration of the stress, but was suppressed when proliferation was restimulated by the addition of serum. The recombinant expression of GFP (green fluorescent protein)-tagged IGFBP-2 in transfected MLE-12 cells demonstrated its ability to bind specifically to p21CIP1/WAF1. Taken together, these results provide a link between IGFBP-2 and p21CIP1/WAF1 in the regulation of alveolar lung cell proliferation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16131350      PMCID: PMC1316284          DOI: 10.1042/BJ20050517

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  42 in total

Review 1.  Functional role of p21 during the cellular response to stress.

Authors:  M Gorospe; X Wang; N J Holbrook
Journal:  Gene Expr       Date:  1999

2.  Involvement of the cell cycle inhibitor CIP1/WAF1 in lung alveolar epithelial cell growth arrest induced by glucocorticoids.

Authors:  S Corroyer; E Nabeyrat; A Clement
Journal:  Endocrinology       Date:  1997-09       Impact factor: 4.736

3.  Overexpression of insulin-like growth factor-binding protein-2 results in increased tumorigenic potential in Y-1 adrenocortical tumor cells.

Authors:  A Hoeflich; O Fettscher; H Lahm; W F Blum; H J Kolb; D Engelhardt; E Wolf; M M Weber
Journal:  Cancer Res       Date:  2000-02-15       Impact factor: 12.701

4.  Retinoic acid-induced proliferation of lung alveolar epithelial cells is linked to p21(CIP1) downregulation.

Authors:  E Nabeyrat; S Corroyer; R Epaud; V Besnard; V Cazals; A Clement
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2000-01       Impact factor: 5.464

5.  Overexpression of insulin-like growth factor-binding protein-2 in transgenic mice reduces postnatal body weight gain.

Authors:  A Hoeflich; M Wu; S Mohan; J Föll; R Wanke; T Froehlich; G J Arnold; H Lahm; H J Kolb; E Wolf
Journal:  Endocrinology       Date:  1999-12       Impact factor: 4.736

6.  The relationship between p21/waf1 expression patterns and cell proliferation during the tumorigenesis of the bronchus.

Authors:  T Hirano; M Kakihana; K Tsuji; H Shibanuma; T Ohira; N Ikeda; N Kawate; C Konaka; Y Ebihara; H Kato
Journal:  Int J Oncol       Date:  1999-08       Impact factor: 5.650

7.  Developmental changes in the expression patterns of IGFs, type 1 IGF receptor and IGF-binding proteins-2 and -4 in perinatal rat lung.

Authors:  D C Batchelor; A M Hutchins; M Klempt; S J Skinner
Journal:  J Mol Endocrinol       Date:  1995-10       Impact factor: 5.098

8.  Apoptosis inhibitory activity of cytoplasmic p21(Cip1/WAF1) in monocytic differentiation.

Authors:  M Asada; T Yamada; H Ichijo; D Delia; K Miyazono; K Fukumuro; S Mizutani
Journal:  EMBO J       Date:  1999-03-01       Impact factor: 11.598

9.  IGFBP-2 expression in a human cell line is associated with increased IGFBP-3 proteolysis, decreased IGFBP-1 expression and increased tumorigenicity.

Authors:  M Menouny; M Binoux; S Babajko
Journal:  Int J Cancer       Date:  1998-09-11       Impact factor: 7.396

10.  Retinoic acid-induced proliferation of lung alveolar epithelial cells: relation with the IGF system.

Authors:  E Nabeyrat; V Besnard; S Corroyer; V Cazals; A Clement
Journal:  Am J Physiol       Date:  1998-07
View more
  9 in total

Review 1.  The IGF-I regulatory system and its impact on skeletal and energy homeostasis.

Authors:  Masanobu Kawai; Clifford J Rosen
Journal:  J Cell Biochem       Date:  2010-09-01       Impact factor: 4.429

2.  IGFBP-2 - taking the lead in growth, metabolism and cancer.

Authors:  Steven W Yau; Walid J Azar; Matthew A Sabin; George A Werther; Vincenzo C Russo
Journal:  J Cell Commun Signal       Date:  2015-01-25       Impact factor: 5.782

3.  PAPA-1 Is a nuclear binding partner of IGFBP-2 and modulates its growth-promoting actions.

Authors:  Kenichi Miyako; Laura J Cobb; Malik Francis; Alden Huang; Bonnie Peng; John E Pintar; Hiroyoshi Ariga; Pinchas Cohen
Journal:  Mol Endocrinol       Date:  2008-12-18

4.  Gemini vitamin D analogues inhibit estrogen receptor-positive and estrogen receptor-negative mammary tumorigenesis without hypercalcemic toxicity.

Authors:  Hong Jin Lee; Shiby Paul; Nadi Atalla; Paul E Thomas; Xinjie Lin; Ill Yang; Brian Buckley; Gang Lu; Xi Zheng; You-Rong Lou; Allan H Conney; Hubert Maehr; Luciano Adorini; Milan Uskokovic; Nanjoo Suh
Journal:  Cancer Prev Res (Phila)       Date:  2008-11

Review 5.  IGF binding proteins in cancer: mechanistic and clinical insights.

Authors:  Robert C Baxter
Journal:  Nat Rev Cancer       Date:  2014-04-10       Impact factor: 60.716

6.  IGFBP2 potentiates nuclear EGFR-STAT3 signaling.

Authors:  C Y Chua; Y Liu; K J Granberg; L Hu; H Haapasalo; M J Annala; D E Cogdell; M Verploegen; L M Moore; G N Fuller; M Nykter; W K Cavenee; W Zhang
Journal:  Oncogene       Date:  2015-04-20       Impact factor: 9.867

7.  Intracellular Insulin-like growth factor binding protein 2 (IGFBP2) contributes to the senescence of keratinocytes in psoriasis by stabilizing cytoplasmic p21.

Authors:  Laura Mercurio; Daniela Lulli; Francesca Mascia; Elena Dellambra; Claudia Scarponi; Martina Morelli; Carola Valente; Maria Luigia Carbone; Sabatino Pallotta; Giampiero Girolomoni; Cristina Albanesi; Saveria Pastore; Stefania Madonna
Journal:  Aging (Albany NY)       Date:  2020-04-17       Impact factor: 5.682

Review 8.  Potential Role of Insulin Growth-Factor-Binding Protein 2 as Therapeutic Target for Obesity-Related Insulin Resistance.

Authors:  Hatim Boughanem; Elena M Yubero-Serrano; José López-Miranda; Francisco J Tinahones; Manuel Macias-Gonzalez
Journal:  Int J Mol Sci       Date:  2021-01-24       Impact factor: 5.923

Review 9.  Understanding the Key to Targeting the IGF Axis in Cancer: A Biomarker Assessment.

Authors:  Kunal Amratlal Lodhia; Piyawan Tienchaiananda; Paul Haluska
Journal:  Front Oncol       Date:  2015-07-08       Impact factor: 6.244

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.